Daily Hand-Held Vibration Therapy

Study Overview
=================
Brief Summary
-----------------
The purpose of this pilot study is to determine the safety and feasibility of a daily 3-minute hand-held vibration therapy intervention to reduce the severity of CIPN in the hands. The investigators hypothesize that daily vibration therapy can reduce the severity of patient's CIPN in their hands and improve CIPN-related quality of life. The hope is that results from this study will provide early data on the feasibility, efficacy, and most importantly, safety, of daily 3-minute hand-held vibration therapy needed to justify future clinical trials examining vibration therapy as a potential option for treating CIPN in the future.

Official Title
-----------------
Daily Hand-Held Vibration Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN): A Pilot Study

Conditions
-----------------
Cancer, Neuropathy, Chemotherapeutic Drug - Induced Nephropathy, Chemotherapeutic Toxicity

Intervention / Treatment
-----------------
* Device: Vibration therapy


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 18 years or older at enrollment Able to provide informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization Have completed chemotherapy ≥ 60 days prior to enrollment Were exposed to neurotoxic chemotherapy with one or more of the following agents in the following doses: Paclitaxel (cumulative dose: ≥ 300 mg/m2) Docetaxel (cumulative dose: ≥ 100 mg/m2) Nab-paclitaxel (cumulative dose: ≥ 750 mg/m2) Oxaliplatin (cumulative dose: ≥ 510 mg/m2) Carboplatin (cumulative dose: ≥ 600 mg/m2) Cisplatin (cumulative dose: ≥ 200 mg/m2) Vincristine (cumulative dose: ≥ 4 mg/m2) Bortezomib (cumulative dose: ≥ 16 mg/m) Continue to display evidence of sensory CIPN in the hands rated at a Grade ≥ 2 according the National Cancer Institute's Common Toxicity Criteria-Adverse Events (NCI-CTC-AE, Version 5.0) Scale ≥ 60 days post-chemotherapy If solid tumor cancer, must have non-metastatic cancer Agree to return to clinic for required study related measurements at specified intervals Exclusion Criteria: Have pre-existing neuropathy affecting the hands not related to chemotherapy (e.g., carpal tunnel syndrome, nerve compression, etc.) Known diagnosis of diabetes mellitus. Known contraindications for vibration therapy to hands, including deep venous thrombosis of the upper extremity or ongoing skin infection. Will be receiving concurrent radiation of the upper-extremity

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Intervention Model: Single Group Assignment
Interventional Model Description: Subjects will be instructed to perform 3-minutes of vibration therapy per hand each day using a hand held vibration device for 4 weeks. The amount of time that subjects perform vibration therapy will be recorded on their Daily Compliance form and subjects will complete questionnaires daily and weekly.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Vibration Therapy<br>Patients will hold a hand held vibrating device for 3 minutes on each hand daily for 4 weeks. | Device: Vibration therapy<br>* vibration therapy using hand held vibration device<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Feasibility of recruitment- percentage of patients who agree to participate in the study after screening |  | recruitment period (up to 1 year after study starts) | 
| Feasibility of compliance- percentage of vibration therapy sessions completed | Compliance with the daily vibration therapy sessions will be evaluated using data from a Daily Compliance Form Researchers will calculate the percentage of sessions that were completed calculated for each participant, on each hand. Participant compliance with the intervention will be considered acceptable if participants complete ≥ 80% of the sessions they were assigned. | 4 weeks | 
| Acceptability of Intervention- percentage of patients who answer agree on acceptability form | percentage of participants who answer somewhat agree, agree, or strongly agree on the intervention acceptability form | 4 weeks | 
| Change in the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy Induced Peripheral Neuropathy twenty-item scale (CIPN20) scores | CIPN 20 questionnaire scores will be compared to baseline weekly to identify an increase of 30% during the intervention period. The CIPN scores range from 20 to 80 with 80 being consistent with the most severe neuropathy symptoms | baseline, week 1, week 2, week 3, week 4 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in CIPN Severity via the CIPN20 questionnaire scores | Summary statistics for the weekly CIPN-20 (n, mean, standard deviation, median, minimum, maximum) | baseline, weeks 1, 2, 3, and 4, 5, 6, 7, and week 8 | 
| Change in CIPN related Quality of Life via the Chemotherapy Induced Peripheral Neuropathy Quality of Life Scale | Descriptive statistics (frequency and percentage for each category, mean and standard deviation of scores assigned to each category (range: 0-7)) will be used to describe the CIPN-related QOL participants have on each of the three categories related to quality of life | baseline, week 4, week 8 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Neuropathy, Vibration